Dynavax Technologies Corporation (DVAX) Dividend History

Company News

• Dynavax (DVAX) Q2 Revenue Jumps 29%

  Dynavax Technologies exceeded Q2 2025 analyst expectations with $95.4 million in revenue and $0.14 EPS, driven by record sales of HEPLISAV-B hepatitis B vaccine and strong market share growth.

  The Motley Fool

  Featured Companies: MRK
• Vaccine Adjuvants Market to Reach USD 5.43 Billion by 2032 Due to Increasing Demand for Enhanced Vaccine Efficacy and Global Immunization Programs – SNS Insider

  The global vaccine adjuvants market is projected to grow from USD 3.83 billion in 2024 to USD 5.43 billion by 2032, with a 4.47% CAGR, driven by increasing vaccine efficacy demands and global immunization programs.

  GlobeNewswire Inc.

  Featured Companies: NVAX
• Dynavax Technologies (DVAX) Reports Q1 Loss, Misses Revenue Estimates

  Dynavax Technologies (DVAX) delivered earnings and revenue surprises of -40% and 2.29%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

  Zacks Investment Research

  Featured Companies: ATRA
• Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session

  Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41. RxSight shares jumped 20% to $44.31 on Monday. Here are some other stocks moving in today's mid-day session. Gainers Harpoon Therapeutics, Inc. (NASDAQ: HARP) shares jumped 111.2% to $22.28 after Merck announced it will acquire the company for $23 per share in cash. Ambrx Biopharma Inc. (NASDAQ: AMAM) jumped 98.1% to $27.00 after Johnson & Johnson announced it will acquire the company in an all-cash merger for a total equity value of approximately $2 billion. Spectaire Holdings Inc. (NASDAQ: SPEC) jumped 75.2% to $2.96. Nkarta, Inc. (NASDAQ: NKTX) rose 51% to $9.17 as the company announced updated corporate presentation to reflect business and strategic update. Universe Pharmaceuticals INC (NASDAQ: UPC) gained 42% to $2.22. Elevation Oncology, Inc. (NASDAQ: ELEV) jumped 39.2% to $1.2193. NexImmune, Inc. (NASDAQ: NEXI) rose 34.7% to $8.32. Praxis Precision Medicines, Inc. (NASDAQ: PRAX) rose 34% to $33.76 as the company issued update on advancing clinical stage portfolio. QuantaSing Group Limited (NASDAQ: QSG) gained 31% to $2.0563. Butterfly Network, Inc. (NASDAQ: BFLY) rose 29.7% to $1.31 as the company announced FDA clearance of handheld ultrasound system, Butterfly iQ3. Venus Concept Inc. (NASDAQ: VERO) climbed 28% to $1.51. Ardelyx, Inc. (NASDAQ: ARDX) gained 25.5% to $7.73 after the company provided an update on its progress in 2023 and initial expectations for 2024. BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 20.8% to $7.36 after the company issued preliminary Q4 revenue guidance above estimates. Also the company said it is approaching positive EPS and cash flow in 2H 2025. Axonics, Inc. (NASDAQ: AXNX) jumped 19.9% to $69.03 after the company announced a deal to be acquired by Boston Scientific. Crocs, Inc. (NASDAQ: CROX) jumped 18.8% to $102.69 after the company issued strong Q4 and full year 2023 guidance. LendingTree, Inc. (NASDAQ: TREE) ...

  Benzinga

  Featured Companies: ARDX AREN AVDL BA BCRX BFLY BNZI BSGM CMC CROX CYCC ELEV FSLY IVP MTC NAK NKTX OPK PACB PRAX PRTA RGNX RXST SGD SHPH SPR STSS STTK TREE UPC UPWK VERO WWW ZJYL
• The Russell 2000 Index has soared, but you might be better off looking elsewhere for quality small-cap stocks

  A more selective small-cap index has consistently outperformed the Russell 2000

  MarketWatch

  Featured Companies: ACRV ALLO ARLO ATNM CMPX CPRX CRBU DGII GPRE HLX IJR INZY IPSC IRWD IWM KPTI LCTX LGND MODV PAYO PCRX PRVA PTEN RCUS RLYB RNA SMTC SPY STOK TALO THRY TNYA TRVI VIGL VIR VOR XFOR XNCR XPER